---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/42048960.md"
description: "$INSILICO(03696.HK) has surged by over a dozen points, and the catalysts are quite clear: ISM8969, an NLRP3 inhibitor discovered by AI, has completed its first human dosing in collaboration with Hengtai Biotech, marking the first true clinical milestone in its AI drug development pipeline. At the same time, it was included in the FTSE Global Index, and passive funds typically front-run before the effective date. One fundamental milestone and one capital flow factor combined, this rally has a solid basis and is not purely speculative."
datetime: "2026-06-22T10:07:42.000Z"
locales:
  - [en](https://longbridge.com/en/topics/42048960.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/42048960.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/42048960.md)
author: "[这个世界需要英雄](https://longbridge.com/en/profiles/27713130.md)"
---

# $INSILICO(03696.HK) has surged by over a dozen poi…


### Related Stocks

- [03696.HK](https://longbridge.com/en/quote/03696.HK.md)